This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4zop
From Proteopedia
(Difference between revisions)
| Line 4: | Line 4: | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4zop]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ZOP OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4ZOP FirstGlance]. <br> | <table><tr><td colspan='2'>[[4zop]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ZOP OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4ZOP FirstGlance]. <br> | ||
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=4Q2:(2S,3R)-N~1~-(8-TERT-BUTYL-4,5-DIHYDRO[1,3]THIAZOLO[4,5-H]QUINAZOLIN-2-YL)-3-METHYLPYRROLIDINE-1,2-DICARBOXAMIDE'>4Q2</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.62Å</td></tr> |
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=4Q2:(2S,3R)-N~1~-(8-TERT-BUTYL-4,5-DIHYDRO[1,3]THIAZOLO[4,5-H]QUINAZOLIN-2-YL)-3-METHYLPYRROLIDINE-1,2-DICARBOXAMIDE'>4Q2</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4zop FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4zop OCA], [https://pdbe.org/4zop PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4zop RCSB], [https://www.ebi.ac.uk/pdbsum/4zop PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4zop ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4zop FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4zop OCA], [https://pdbe.org/4zop PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4zop RCSB], [https://www.ebi.ac.uk/pdbsum/4zop PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4zop ProSAT]</span></td></tr> | ||
</table> | </table> | ||
Current revision
Co-crystal Structure of Lipid Kinase PI3K alpha with a selective phosphatidylinositol-3 kinase alpha inhibitor
| |||||||||||
